Advertisement

Neonatology pp 1223-1241 | Cite as

Neonatal Cholestasis: Conjugated Hyperbilirubinemia

  • Nandini Kataria
  • Glenn R. Gourley
Reference work entry

Abstract

Jaundice during the first few weeks of life is a common finding. Frequently, such jaundice is due to elevation of the unconjugated, or indirect, bilirubin and is often the result of a benign process. More concerning is jaundice due to elevation of the conjugated bilirubin fraction. Neonatal cholestasis is defined as an accumulation of biliary substances, such as bilirubin and bile acids because of impaired canalicular bile flow. Neonatal cholestasis manifests with a conjugated hyperbilirubinemia and must be differentiated from unconjugated hyperbilirubinemia, as it is more often associated with a specific disease process. The incidence of neonatal cholestasis has been estimated at 1 in 2,500 live births.

References

  1. Abdel-Kader HH, Balistreri WF (1994) Neonatal hepatobiliary disease. Semin Gastrointest Dis 5(2):65–77Google Scholar
  2. Abramson SJ, Treves S, Teele RL (1982) The infant with possible biliary atresia: evaluation by ultrasound and nuclear medicine. Pediatr Radiol 12(1):1–5CrossRefGoogle Scholar
  3. Azar G, Beneck D, Lane B, Markowitz J, Daum F, Kahn E (2002) Atypical morphologic presentation of biliary atresia and value of serial liver biopsies. J Pediatr Gastroenterol Nutr 34(2):212–215CrossRefGoogle Scholar
  4. Bates MD, Bucuvalas JC, Alonso MH, Ryckman FC (1998) Biliary atresia: pathogenesis and treatment. Semin Liver Dis 18(3):281–293CrossRefGoogle Scholar
  5. Bergasa NV (2008) Update on the treatment of the pruritus of cholestasis. Clin Liver Dis 12(1):219–234, xCrossRefGoogle Scholar
  6. Bergasa NV, Jones EA (1995) The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids. Gastroenterology 108(5):1582–1588CrossRefGoogle Scholar
  7. Bergasa NV, Talbot TL, Alling DW et al (1992) A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 102(2):544–549CrossRefGoogle Scholar
  8. Bergasa NV, Link MJ, Keogh M, Yaroslavsky G, Rosenthal RN, McGee M (2001) Pilot study of bright-light therapy reflected toward the eyes for the pruritus of chronic liver disease. Am J Gastroenterol 96(5):1563–1570CrossRefGoogle Scholar
  9. Bezerra JA (2005) Potential etiologies of biliary atresia. Pediatr Transplant 9(5):646–651CrossRefGoogle Scholar
  10. Bezerra JA, Spino C, Magee JC et al (2014) Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. JAMA 311(17):1750–1759CrossRefGoogle Scholar
  11. Bijl EJ, Bharwani KD, Houwen RH, de Man RA (2013) The long-term outcome of the Kasai operation in patients with biliary atresia: a systematic review. Neth J Med 71(4):170–173PubMedGoogle Scholar
  12. Bittmann S (2005) Surgical experience in children with biliary atresia treated with portoenterostomy. Curr Surg 62(4):439–443CrossRefGoogle Scholar
  13. Boyer JL (2013) Bile formation and secretion. Compr Physiol 3(3):1035–1078PubMedPubMedCentralGoogle Scholar
  14. Browning J, Combes B, Mayo MJ (2003) Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol 98(12):2736–2741CrossRefGoogle Scholar
  15. Bu LN, Chen HL, Chang CJ et al (2003) Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy. J Pediatr Surg 38(4):590–593CrossRefGoogle Scholar
  16. Cabrera-Abreu JC, Green A (2002) Gamma-glutamyltransferase: value of its measurement in paediatrics. Ann Clin Biochem 39(Pt 1):22–25CrossRefGoogle Scholar
  17. Calleja C, Pascussi JM, Mani JC, Maurel P, Vilarem MJ (1998) The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor. Nat Med 4(1):92–96CrossRefGoogle Scholar
  18. Chang Y, Golkar L (2008) The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case. Pediatr Dermatol 25(3):403–404CrossRefGoogle Scholar
  19. Chen Y, Nah SA, Chiang L, Krishnaswamy G, Low Y (2015) Postoperative steroid therapy for biliary atresia: systematic review and meta-analysis. J Pediatr Surg 50(9):1590–1594CrossRefGoogle Scholar
  20. Chung HY, Kak Yuen Wong K, Cheun Leung Lan L, Kwong Hang Tam P (2008) Evaluation of a standardized protocol in the use of steroids after Kasai operation. Pediatr Surg Int. 2008 Sep;24(9):1001–1004.CrossRefGoogle Scholar
  21. Cies JJ, Giamalis JN (2007) Treatment of cholestatic pruritus in children. Am J Health-Syst Pharm 64(11):1157–1162CrossRefGoogle Scholar
  22. Coakley RJ, Taggart C, O’Neill S, McElvaney NG (2001) Alpha1-antitrypsin deficiency: biological answers to clinical questions. Am J Med Sci 321(1):33–41CrossRefGoogle Scholar
  23. Dani C, Pratesi S, Raimondi F, Romagnoli C, Task Force for Hyperbilirubinemia of the Italian Society of Neonatology (2015) Italian guidelines for the management and treatment of neonatal cholestasis. Ital J Pediatr 41:69CrossRefGoogle Scholar
  24. Davenport M, Kerkar N, Mieli-Vergani G, Mowat AP, Howard ER (1997) Biliary atresia: the King’s College Hospital experience (1974–1995). J Pediatr Surg 32(3):479–485CrossRefGoogle Scholar
  25. Dehghani SM, Haghighat M, Imanieh MH, Geramizadeh B (2006) Comparison of different diagnostic methods in infants with cholestasis. World J Gastroenterol 12(36):5893–5896CrossRefGoogle Scholar
  26. Diehn F, Tefferi A (2001) Pruritus in polycythaemia vera: prevalence, laboratory correlates and management. Br J Haematol 115(3):619–621CrossRefGoogle Scholar
  27. Dillon S, Tobias JD (2013) Ondansetron to treat pruritus due to cholestatic jaundice. J Pediatr Pharmacol Ther 18(3):241–246PubMedPubMedCentralGoogle Scholar
  28. Eaves ER, Korman MG (1984) Cholestyramine induced hyperchloremic metabolic acidosis. Aust N Z J Med 14(5):670–672CrossRefGoogle Scholar
  29. Ermis F, Oncu K, Ozel M et al (2010) Benign recurrent intrahepatic cholestasis: late initial diagnosis in adulthood. Ann Hepatol 9(2):207–210PubMedGoogle Scholar
  30. Feldman AG, Mack CL (2012) Biliary atresia: cellular dynamics and immune dysregulation. Semin Pediatr Surg 21(3):192–200CrossRefGoogle Scholar
  31. Fischler B, Papadogiannakis N, Nemeth A (2001) Clinical aspects on neonatal cholestasis based on observations at a Swedish tertiary referral centre. Acta Paediatr 90(2):171–178CrossRefGoogle Scholar
  32. Francavilla R, Castellaneta SP, Hadzic N et al (2000) Prognosis of alpha-1-antitrypsin deficiency-related liver disease in the era of paediatric liver transplantation. J Hepatol 32(6):986–992CrossRefGoogle Scholar
  33. Frederick Suchy RS (2007) Liver disease in children, 3rd edn. Cambridge University Press, New YorkCrossRefGoogle Scholar
  34. Frigon C, Desparmet J (2006) Ondansetron treatment in a child presenting with chronic intractable pruritus. Pain Res Manag: J Can Pain Soc 11(4):245–247CrossRefGoogle Scholar
  35. Gourley GR, Yang L, Higgins L, Riviere MA, David LL (2009) Proteomic analysis of biopsied human colonic mucosa. J Pediatr Gastroenterol Nutr. 2010 Jul;51(1):46–54CrossRefGoogle Scholar
  36. Haber BA, Russo P (2003) Biliary atresia. Gastroenterol Clin North Am 32(3):891–911CrossRefGoogle Scholar
  37. Hegade VS, Kendrick SF, Jones DE (2015) Drug treatment of pruritus in liver diseases. Clin Med 15(4):351–357Google Scholar
  38. Herzog D, Chessex P, Martin S, Alvarez F (2003) Transient cholestasis in newborn infants with perinatal asphyxia. Can J Gastroenterol 17(3):179–182CrossRefGoogle Scholar
  39. Hirfanoglu IM, Unal S, Onal EE et al (2014) Analysis of serum gamma-glutamyl transferase levels in neonatal intensive care unit patients. J Pediatr Gastroenterol Nutr 58(1):99–101CrossRefGoogle Scholar
  40. Hori T, Nguyen JH, Uemoto S (2010) Progressive familial intrahepatic cholestasis. Hepatobiliary Pancreat Dis Int 9(6):570–578PubMedGoogle Scholar
  41. Houwen RH, Zwierstra RP, Severijnen RS et al (1989) Prognosis of extrahepatic biliary atresia. Arch Dis Child 64(2):214–218CrossRefGoogle Scholar
  42. Hsieh MH, Pai W, Tseng HI, Yang SN, Lu CC, Chen HL (2009) Parenteral nutrition-associated cholestasis in premature babies: risk factors and predictors. Pediatr Neonatol 50(5):202–207CrossRefGoogle Scholar
  43. Kamath BM, Loomes KM, Oakey RJ, Krantz ID (2002) Supernumerary digital flexion creases: an additional clinical manifestation of Alagille syndrome. Am J Med Genet 112(2):171–175PubMedGoogle Scholar
  44. Kamath BM, Spinner NB, Emerick KM et al (2004) Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation 109(11):1354–1358CrossRefGoogle Scholar
  45. Kotb MA, Kotb A, Sheba MF et al (2001) Evaluation of the triangular cord sign in the diagnosis of biliary atresia. Pediatrics 108(2):416–420CrossRefGoogle Scholar
  46. Kremer AE, Gonzales E, Schaap FG, Elferink RP, Jacquemin E, Beuers U (2015) Serum autotaxin activity correlates with pruritus in pediatric cholestatic disorders. J Pediatr Gastroenterol Nutr 2016 Apr;62(4):530–535CrossRefGoogle Scholar
  47. Lai MW, Chang MH, Hsu SC et al (1994) Differential diagnosis of extrahepatic biliary atresia from neonatal hepatitis: a prospective study. J Pediatr Gastroenterol Nutr 18(2):121–127CrossRefGoogle Scholar
  48. Larrosa-Haro A, Caro-Lopez AM, Coello-Ramirez P, Zavala-Ocampo J, Vazquez-Camacho G (2001) Duodenal tube test in the diagnosis of biliary atresia. J Pediatr Gastroenterol Nutr 32(3):311–315CrossRefGoogle Scholar
  49. Lee MS, Kim MJ, Lee MJ et al (2009) Biliary atresia: color Doppler US findings in neonates and infants. Radiology 252(1):282–289CrossRefGoogle Scholar
  50. Liu B, Cai J, Xu Y et al (2014) Three-dimensional magnetic resonance cholangiopancreatography for the diagnosis of biliary atresia in infants and neonates. PLoS One 9(2):e88268CrossRefGoogle Scholar
  51. Lomas DA, Evans DL, Finch JT, Carrell RW (1992) The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 357(6379):605–607CrossRefGoogle Scholar
  52. Maxwell LG, Kaufmann SC, Bitzer S et al (2005) The effects of a small-dose naloxone infusion on opioid-induced side effects and analgesia in children and adolescents treated with intravenous patient-controlled analgesia: a double-blind, prospective, randomized, controlled study. Anesth Analg 100(4):953–958CrossRefGoogle Scholar
  53. McClement JW, Howard ER, Mowat AP (1985) Results of surgical treatment for extrahepatic biliary atresia in United Kingdom 1980–2. Survey conducted on behalf of the British Paediatric Association Gastroenterology Group and the British Association of Paediatric Surgeons. Br Med J (Clin Res Ed) 290(6465):345–347CrossRefGoogle Scholar
  54. McDaniell R, Warthen DM, Sanchez-Lara PA et al (2006) NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 79(1):169–173CrossRefGoogle Scholar
  55. Mitchison HC, Bassendine MF, Malcolm AJ, Watson AJ, Record CO, James OF (1989) A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss. Hepatology (Baltimore, Md) 10(4):420–429CrossRefGoogle Scholar
  56. Monajemzadeh M, Shahsiah R, Vasei M et al (2013) Alpha 1 antitrypsin deficiency in infants with neonatal cholestasis. Iran J Pediatr 23(5):501–507PubMedPubMedCentralGoogle Scholar
  57. Moyer V, Freese DK, Whitington PF et al (2004) Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 39(2):115–128CrossRefGoogle Scholar
  58. Nguyen KD, Sundaram V, Ayoub WS (2014) Atypical causes of cholestasis. World J Gastroenterol 20(28):9418–9426PubMedPubMedCentralGoogle Scholar
  59. Oude Elferink RP, Kremer AE, Beuers U (2011) Mediators of pruritus during cholestasis. Curr Opin Gastroenterol 27(3):289–293CrossRefGoogle Scholar
  60. Park WH, Choi SO, Lee HJ, Kim SP, Zeon SK, Lee SL (1997) A new diagnostic approach to biliary atresia with emphasis on the ultrasonographic triangular cord sign: comparison of ultrasonography, hepatobiliary scintigraphy, and liver needle biopsy in the evaluation of infantile cholestasis. J Pediatr Surg 32(11):1555–1559CrossRefGoogle Scholar
  61. Pusl T, Denk GU, Parhofer KG, Beuers U (2006) Plasma separation and anion adsorption transiently relieve intractable pruritus in primary biliary cirrhosis. J Hepatol 45(6):887–891CrossRefGoogle Scholar
  62. Rifai K, Hafer C, Rosenau J et al (2006) Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus). Scand J Gastroenterol 41(10):1212–1217CrossRefGoogle Scholar
  63. Seckin D, Demircay Z, Akin O (2007) Generalized pruritus treated with narrowband UVB. Int J Dermatol 46(4):367–370CrossRefGoogle Scholar
  64. Sergi C, Benstz J, Feist D, Nutzenadel W, Otto HF, Hofmann WJ (2008) Bile duct to portal space ratio and ductal plate remnants in liver disease of infants aged less than 1 year. Pathology 40(3):260–267CrossRefGoogle Scholar
  65. Shojania AM, Grewar D (1986) Hypoprothrombinemic hemorrhage due to cholestyramine therapy. CMAJ 134(6):609–610PubMedPubMedCentralGoogle Scholar
  66. Shteyer E, Wengrower D, Benuri-Silbiger I, Gozal D, Wilschanski M, Goldin E (2012) Endoscopic retrograde cholangiopancreatography in neonatal cholestasis. J Pediatr Gastroenterol Nutr 55(2):142–145CrossRefGoogle Scholar
  67. Soroka CJ, Boyer JL (2014) Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations. Mol Aspects Med 37:3–14CrossRefGoogle Scholar
  68. Srivastava A (2014) Progressive familial intrahepatic cholestasis. J Clin Exp Hepatol 4(1):25–36CrossRefGoogle Scholar
  69. Steinbach M, Clark RH, Kelleher AS et al (2008) Demographic and nutritional factors associated with prolonged cholestatic jaundice in the premature infant. J Perinatol: Off J Calif Perinat Assoc 28(2):129–135CrossRefGoogle Scholar
  70. Strubbe B, Geerts A, Van Vlierberghe H, Colle I (2012) Progressive familial intrahepatic cholestasis and benign recurrent intrahepatic cholestasis: a review. Acta Gastro-Enterologica Belgica 75(4):405–410PubMedGoogle Scholar
  71. Teckman JH (2013) Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy. COPD 10(Suppl 1):35–43CrossRefGoogle Scholar
  72. Torbenson M, Hart J, Westerhoff M et al (2010) Neonatal giant cell hepatitis: histological and etiological findings. Am J Surg Pathol 34(10):1498–1503CrossRefGoogle Scholar
  73. Turnpenny PD, Ellard S (2012) Alagille syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet: EJHG 20(3):251–257CrossRefGoogle Scholar
  74. Tyraskis A, Davenport M (2015) Steroids after the Kasai procedure for biliary atresia: the effect of age at Kasai portoenterostomy. Pediatr Surg Int. 2016 Mar;32(3):193–200.CrossRefGoogle Scholar
  75. Venigalla S, Gourley GR (2004) Neonatal cholestasis. Semin Perinatol 28(5):348–355CrossRefGoogle Scholar
  76. Walker WA, Kleinman R et al (2004) Pediatric gastrointestinal disease: pathophysiology, diagnosis, management, 3rd edn. B.C. Decker, HamiltonGoogle Scholar
  77. Wang JS, Tan N, Dhawan A (2006) Significance of low or normal serum gamma glutamyl transferase level in infants with idiopathic neonatal hepatitis. Eur J Pediatr 165(11):795–801CrossRefGoogle Scholar
  78. Yang JG, Ma DQ, Peng Y, Song L, Li CL (2009) Comparison of different diagnostic methods for differentiating biliary atresia from idiopathic neonatal hepatitis. Clin Imaging 33(6):439–446CrossRefGoogle Scholar
  79. Zylicz Z, Smits C, Krajnik M (1998) Paroxetine for pruritus in advanced cancer. J Pain Symptom Manage 16(2):121–124CrossRefGoogle Scholar
  80. Zylicz Z, Krajnik M, Sorge AA, Costantini M (2003) Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage 26(6):1105–1112CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of PediatricsUniversity of MinnesotaLong BeachUSA
  2. 2.Department of PediatricsUniversity of MinnesotaMinneapolisUSA

Personalised recommendations